Controversial1 Alzheimer’s drug lecanemab has overcome another regulatory hurdle, with Australia’s drugs regulator approving the therapy after two rejections.2 The drug, made by Eisai, faces an uphill ...
A person's well-being is affected by many different factors. Our life experiences and the environment have a profound effect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback